Cargando…

Impact of LEDGIN treatment during virus production on residual HIV-1 transcription

BACKGROUND: Persistence of latent, replication-competent provirus is the main impediment towards the cure of HIV infection. One of the critical questions concerning HIV latency is the role of integration site selection in HIV expression. Inhibition of the interaction between HIV integrase and its ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Vansant, Gerlinde, Vranckx, Lenard S., Zurnic, Irena, Van Looveren, Dominique, Van de Velde, Paulien, Nobles, Christopher, Gijsbers, Rik, Christ, Frauke, Debyser, Zeger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444612/
https://www.ncbi.nlm.nih.gov/pubmed/30940165
http://dx.doi.org/10.1186/s12977-019-0472-3
_version_ 1783408058294075392
author Vansant, Gerlinde
Vranckx, Lenard S.
Zurnic, Irena
Van Looveren, Dominique
Van de Velde, Paulien
Nobles, Christopher
Gijsbers, Rik
Christ, Frauke
Debyser, Zeger
author_facet Vansant, Gerlinde
Vranckx, Lenard S.
Zurnic, Irena
Van Looveren, Dominique
Van de Velde, Paulien
Nobles, Christopher
Gijsbers, Rik
Christ, Frauke
Debyser, Zeger
author_sort Vansant, Gerlinde
collection PubMed
description BACKGROUND: Persistence of latent, replication-competent provirus is the main impediment towards the cure of HIV infection. One of the critical questions concerning HIV latency is the role of integration site selection in HIV expression. Inhibition of the interaction between HIV integrase and its chromatin tethering cofactor LEDGF/p75 is known to reduce integration and to retarget residual provirus to regions resistant to reactivation. LEDGINs, small molecule inhibitors of the interaction between HIV integrase and LEDGF/p75, provide an interesting tool to study the underlying mechanisms. During early infection, LEDGINs block the interaction with LEDGF/p75 and allosterically inhibit the catalytic activity of IN (i.e. the early effect). When present during virus production, LEDGINs interfere with proper maturation due to enhanced IN oligomerization in the progeny virions (i.e. the late effect). RESULTS: We studied the effect of LEDGINs present during virus production on the transcriptional state of the residual virus. Infection of cells with viruses produced in the presence of LEDGINs resulted in a residual reservoir that was refractory to activation. Integration of residual provirus was less favored near epigenetic markers associated with active transcription. However, integration near H3K36me3 and active genes, both targeted by LEDGF/p75, was not affected. Also in primary cells, LEDGIN treatment induced a reservoir resistant to activation due to a combined early and late effect. CONCLUSION: LEDGINs present a research tool to study the link between integration and transcription, an essential question in retrovirology. LEDGIN treatment during virus production altered integration of residual provirus in a LEDGF/p75-independent manner, resulting in a reservoir that is refractory to activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12977-019-0472-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6444612
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64446122019-04-11 Impact of LEDGIN treatment during virus production on residual HIV-1 transcription Vansant, Gerlinde Vranckx, Lenard S. Zurnic, Irena Van Looveren, Dominique Van de Velde, Paulien Nobles, Christopher Gijsbers, Rik Christ, Frauke Debyser, Zeger Retrovirology Research BACKGROUND: Persistence of latent, replication-competent provirus is the main impediment towards the cure of HIV infection. One of the critical questions concerning HIV latency is the role of integration site selection in HIV expression. Inhibition of the interaction between HIV integrase and its chromatin tethering cofactor LEDGF/p75 is known to reduce integration and to retarget residual provirus to regions resistant to reactivation. LEDGINs, small molecule inhibitors of the interaction between HIV integrase and LEDGF/p75, provide an interesting tool to study the underlying mechanisms. During early infection, LEDGINs block the interaction with LEDGF/p75 and allosterically inhibit the catalytic activity of IN (i.e. the early effect). When present during virus production, LEDGINs interfere with proper maturation due to enhanced IN oligomerization in the progeny virions (i.e. the late effect). RESULTS: We studied the effect of LEDGINs present during virus production on the transcriptional state of the residual virus. Infection of cells with viruses produced in the presence of LEDGINs resulted in a residual reservoir that was refractory to activation. Integration of residual provirus was less favored near epigenetic markers associated with active transcription. However, integration near H3K36me3 and active genes, both targeted by LEDGF/p75, was not affected. Also in primary cells, LEDGIN treatment induced a reservoir resistant to activation due to a combined early and late effect. CONCLUSION: LEDGINs present a research tool to study the link between integration and transcription, an essential question in retrovirology. LEDGIN treatment during virus production altered integration of residual provirus in a LEDGF/p75-independent manner, resulting in a reservoir that is refractory to activation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12977-019-0472-3) contains supplementary material, which is available to authorized users. BioMed Central 2019-04-02 /pmc/articles/PMC6444612/ /pubmed/30940165 http://dx.doi.org/10.1186/s12977-019-0472-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Vansant, Gerlinde
Vranckx, Lenard S.
Zurnic, Irena
Van Looveren, Dominique
Van de Velde, Paulien
Nobles, Christopher
Gijsbers, Rik
Christ, Frauke
Debyser, Zeger
Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
title Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
title_full Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
title_fullStr Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
title_full_unstemmed Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
title_short Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
title_sort impact of ledgin treatment during virus production on residual hiv-1 transcription
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444612/
https://www.ncbi.nlm.nih.gov/pubmed/30940165
http://dx.doi.org/10.1186/s12977-019-0472-3
work_keys_str_mv AT vansantgerlinde impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT vranckxlenards impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT zurnicirena impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT vanlooverendominique impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT vandeveldepaulien impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT nobleschristopher impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT gijsbersrik impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT christfrauke impactofledgintreatmentduringvirusproductiononresidualhiv1transcription
AT debyserzeger impactofledgintreatmentduringvirusproductiononresidualhiv1transcription